<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-280 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-280</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-280</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-5.html">extraction-schema-5</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation prevalence in lung cancer across different ethnic populations, particularly comparing East Asian and non-Asian populations, including frequencies, patient characteristics, environmental factors, and proposed explanations for ethnic differences.</div>
                <p><strong>Paper ID:</strong> paper-164502a687f04effb4ac5dadbdd9d806fde4264c</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/164502a687f04effb4ac5dadbdd9d806fde4264c" target="_blank">Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases.</a></p>
                <p><strong>Paper Venue:</strong> Journal of Clinical Oncology</p>
                <p><strong>Paper TL;DR:</strong> This study represents the first comprehensive and concurrent analysis of major recurrent oncogenic mutations found in a large cohort of lung adenocarcinomas from East Asian never-smokers and indicates that prospective mutation testing in these patients should successfully assign a targeted therapy in the majority of cases.</p>
                <p><strong>Cost:</strong> 0.011</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e280.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e280.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation prevalence in lung cancer across different ethnic populations, particularly comparing East Asian and non-Asian populations, including frequencies, patient characteristics, environmental factors, and proposed explanations for ethnic differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>EGFR_EastAsian_never-smokers</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>EGFR kinase domain mutations in East Asian (Chinese) never-smokers with lung adenocarcinoma</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>This study measured EGFR kinase domain mutations in 52 resected lung adenocarcinomas from Chinese never-smokers and found a very high prevalence (78.8%), dominated by exon 19 deletions and L858R substitutions with a small number of other activating variants.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>here</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>52 consecutively collected resected lung adenocarcinomas from never-smokers (<100 cigarettes lifetime) at Shanghai Cancer Hospital, Fudan University; all patients were Chinese (East Asian); 52 patients: 41 female, 11 male; ages mean ~59 years; stages I-IV included.</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_type</strong></td>
                            <td>Exon 19 deletions (21 cases), L858R exon 21 substitutions (18 cases), one exon 20 insertion, one double mutation (G719S in exon 18 + L861Q in exon 21); no T790M detected.</td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_asian</strong></td>
                            <td>78.8% (41/52)</td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_non_asian</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>has_comparative_ethnic_data</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>patient_smoking_status</strong></td>
                            <td>All patients were never-smokers (study inclusion); among EGFR-mutant cases 82.9% (34/41) were female and 17.1% (7/41) were male; overall cohort 100% never-smokers.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_histology</strong></td>
                            <td>Lung adenocarcinoma</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td>The paper emphasizes smoking exposure as relevant (pack-years inversely associated with EGFR mutation likelihood in cited literature) but does not report other environmental exposures (no specific air pollution, cooking fume, or occupational exposures analyzed in this cohort).</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td>No specific germline or ancestry genetic determinants of higher EGFR mutation prevalence are identified in this study; the paper notes that T790M can rarely occur as a germline variant but none were found here.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>The authors do not propose a molecular or evolutionary mechanism explaining higher EGFR mutation prevalence in East Asians; they attribute enrichment to clinical features (never-smoking status, adenocarcinoma histology, East Asian ethnicity) described in prior studies and emphasize the therapeutic relevance of genotyping.</td>
                        </tr>
                        <tr>
                            <td><strong>odds_ratio_or_risk</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Single-institution Chinese surgical series (selection of resected tumors), predominance of female patients, and restriction to never-smokers limit direct generalization or direct ethnic comparison; the study does not provide population-level controls of non-Asian cohorts.</td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>In this cohort of Chinese never-smokers with lung adenocarcinoma, 78.8% (41/52) harbored EGFR activating kinase mutations (mainly exon 19 deletions and L858R). EGFR mutations were more frequent in females (82.9% of female tumors) than males (63.6%), and the high prevalence helps explain high response rates to EGFR TKIs in East Asian never/light-smoker clinical trials; the paper does not provide direct comparative prevalence numbers for non-Asian populations but references prior literature linking EGFR mutations with East Asian ethnicity and never-smoking status.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases.', 'publication_date_yy_mm': '2010-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e280.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e280.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation prevalence in lung cancer across different ethnic populations, particularly comparing East Asian and non-Asian populations, including frequencies, patient characteristics, environmental factors, and proposed explanations for ethnic differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>EGFR_ethnicity_mentions</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Mentions of ethnic differences in EGFR mutation prevalence and TKI response (prior literature cited)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The paper cites prior retrospective and clinical-trial literature reporting that EGFR mutations and responses to EGFR TKIs are enriched in patients with adenocarcinoma histology, never-smoking status, and East Asian ethnicity, and it cites trials (eg, IPASS) that enrolled East Asian never/light-smokers showing differential benefit by mutation status.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>here</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Not a new study population in this paper; references to prior studies that included East Asian cohorts (eg, IPASS: previously untreated advanced pulmonary adenocarcinoma patients in East Asia who were never- or light-smokers) and to studies including white never-smokers, but no new non-Asian cohort data are analyzed here.</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_type</strong></td>
                            <td>Prior studies referenced particularly associate classical activating EGFR mutations (exon 19 deletions and L858R) with clinical response; no new mutation types reported here beyond those in the primary cohort.</td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_asian</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_non_asian</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>has_comparative_ethnic_data</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>patient_smoking_status</strong></td>
                            <td>Prior literature cited indicates never-smokers and former light-smokers are enriched for EGFR mutations; IPASS enrolled never-smokers or former light-smokers in East Asia.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_histology</strong></td>
                            <td>Adenocarcinoma emphasized in cited literature as the histology associated with EGFR mutations.</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td>Cited literature (reviewed in introduction) notes environmental risk factors for lung cancer in never-smokers more broadly, but this paper does not specify particular environmental exposures as explanations for ethnic differences.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td>The paper cites literature showing certain mutation patterns differ by ancestry for other genes (eg, LKB1 mutations more frequent in Caucasians than Asians) but offers no direct genetic-ancestry explanations for EGFR differences.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>No mechanistic explanation for ethnic differences in EGFR mutation prevalence is offered in the cited or present data; the association is described as an observed clinical/molecular correlation (East Asian ethnicity + never-smoking + adenocarcinoma â†’ higher EGFR mutation likelihood).</td>
                        </tr>
                        <tr>
                            <td><strong>odds_ratio_or_risk</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>The paper acknowledges that smoking history (pack-years) modifies EGFR mutation likelihood and that clinical-trial populations (eg, IPASS) were enriched for East Asian never/light-smokers, suggesting that differences across studies/populations could be influenced by smoking patterns, selection criteria, or trial eligibility rather than pure ethnicity alone.</td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>The authors reiterate that prior retrospective and clinical-trial data associate EGFR mutations with East Asian ethnicity, female sex, adenocarcinoma histology, and never-smoking status; however, this paper provides high-quality prevalence data only for an East Asian never-smoker surgical cohort and does not present direct non-Asian prevalence comparisons or mechanistic explanations.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases.', 'publication_date_yy_mm': '2010-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma <em>(Rating: 2)</em></li>
                <li>Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications <em>(Rating: 2)</em></li>
                <li>Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients <em>(Rating: 2)</em></li>
                <li>Screening for epidermal growth factor receptor mutations in lung cancer <em>(Rating: 2)</em></li>
                <li>Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas <em>(Rating: 1)</em></li>
                <li>EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy <em>(Rating: 1)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>